Home TRANG CHỦ Thứ 6, ngày 29/03/2024
    Hỏi đáp   Diễn đàn   Sơ đồ site     Liên hệ     English
IMPE-QN
Web Sites & Commerce Giới thiệu
Web Sites & Commerce Tin tức - Sự kiện
Web Sites & Commerce Hoạt động hợp tác
Web Sites & Commerce Hoạt động đào tạo
Web Sites & Commerce Chuyên đề
Web Sites & Commerce Tư vấn sức khỏe
Web Sites & Commerce Tạp chí-Ấn phẩm
Finance & Retail Thư viện điện tử
Công trình nghiên cứu về Ký sinh trùng
Công trình nghiên cứu về Sốt rét & SXH
Công trình nghiên cứu về Côn trùng & véc tơ truyền
Đề tài NCKH đã nghiệm thu
Thông tin-Tư liệu NCKH
Web Sites & Commerce Hoạt động Đảng & Đoàn thể
Web Sites & Commerce Bạn trẻ
Web Sites & Commerce Văn bản pháp quy
Số liệu thống kê
Web Sites & Commerce An toàn thực phẩm & hóa chất
Web Sites & Commerce Thầy thuốc và Danh nhân
Web Sites & Commerce Ngành Y-Vinh dự và trách nhiệm
Web Sites & Commerce Trung tâm dịch vụ
Web Sites & Commerce Thông báo-Công khai
Web Sites & Commerce Góc thư giản

Tìm kiếm

Đăng nhập
Tên truy cập
Mật khẩu

WEBLINKS
Website liên kết khác
 
 
Số lượt truy cập:
5 2 2 8 9 9 5 1
Số người đang truy cập
2 8
 Thư viện điện tử Công trình nghiên cứu về Sốt rét & SXH
Một số ấn phẩm cập nhật về đánh giá hiệu lực & hiệu quả thuốc Thiabendazole

Thiabendazole (với nhiều biệt dược khác nhau như Mintazol, Niczen) là một trong nhũng thuốc có hiệu lực cao trong điều trị một số bệnh giun tròn ở người và điều trị cả hội chứng ấu trùng di chuyển ở da niêm mạc hay ở phủ tạng có hiệu quả với tác dụng ngoại ý thấp.

Nhằm chia sẻ với các đồng nghiệp về các ấn bản nghiên cứu về hiệu lực thuốc này, chúng tôi xin giới thiệu một số ấn bản liên quan đến đánh giá các thuốc này trên thế giới.

1.A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. [1995.12]

2.Comparative efficacy of levamisole, thiabendazole and fenbendazole against cattle gastrointestinal nematodes. [1995.05]

3.A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. [1994.05]

4.Theophylline and antiparasitic drug interactions. A case report and study of the influence of thiabendazole and mebendazole o­n theophylline pharmacokinetics in adults. [1990.01]

5.Thiabendazole vs. albendazole in treatment of toxocariasis: a clinical trial. [1989.10]

6.Topical treatment of tungiasis: a randomized, controlled trial. [2003.10]

7.Prevalence of anthelmintic resistance in gastrointestinal nematodes of dairy goats under extensive management conditions in southwestern France. [2001.12]

8.Cutaneous larva migrans: clinical features and management of 44 cases presenting in the returning traveller. [2001.09]

9.Blinded, placebo-controlled trial of antiparasitic drugs for trichinosis myositis. [2000.07]

10.Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali. [1997.07]

11.Chemotherapy of African AIDS diarrhoea: a preliminary study. [1993.01]

12.Randomized trial of albendazole versus tiabendazole plus flubendazole during an outbreak of human trichinellosis. [1988]

13.Randomized clinical trial o­n ivermectin versus thiabendazole for the treatment of strongyloidiasis. [2011.07]

14.Assessment of potential immunotoxic effects caused by cypermethrin, fluoxetine, and thiabendazole using heat shock protein 70 and interleukin-1beta mRNA expression in the anuran Xenopus laevis. [2010.11]

15.Assessment of potential immunotoxic effects caused by cypermethrin, fluoxetine, and thiabendazole using heat shock protein 70 and interleukin-1beta mRNA expression in the anuran Xenopus laevis. [2010.07.24]

16.Factors affecting the synergy of thiabendazole, sodium bicarbonate, and heat to control postharvest green mold of citrus fruit. [2008.11.26]

17.Efficacy of thiabendazole, mebendazole, levamisole and ivermectin against gullet worm, Gongylonema pulchrum: in vitro and in vivo studies. [2008.01.25]

18.[Miticidal efficacy of thiabendazole against Otodectes cynotis (Hering, 1838) in dogs] [2006.10]

19.[Thiabendazole for the control of Strongyloides stercoralis infection in a hyperendemic area in Peru] [2005.10]

20.A novel genotoxic aspect of thiabendazole as a photomutagen in bacteria and cultured human cells. [2005.09.15]

21.Effect of thiabendazole o­n some rat hepatic xenobiotic metabolising enzymes. [2004.06]

22.Synthesis, X-ray crystal structure, antimicrobial activity and photodynamic effects of some thiabendazole complexes. [2004.02]

23.Effects of thiabendazole in Mansonella perstans filariasis. [2003.12]

24.Treatment of pediculosis capitis with thiabendazole: a pilot study. [2003.12]

25.Residue uptake and storage responses of Tarocco blood oranges after preharvest thiabendazole spray and postharvest heat treatment. [2002.04.10]

26.Thiabendazole uptake and storage performance of cactus pear [Opuntia ficus-indica (L.) Mill. Cv Gialla] fruit following postharvest treatments with reduced doses of fungicide at 52 degrees C. [2002.02.13]

27.Chronic toxicity of thiabendazole (TBZ) in CD-1 mice. [2001.12.28]

28.Treatment of widespread cutaneous larva migrans with thiabendazole. [2001.11]

29.Nematocidal activities of thiabendazole and ivermectin against the larvae of Strongyloides ratti and S. venezuelensis. [2001.08.31]

30.Thiabendazole induces urinary tract toxicity in male ICR mice. [2001.04.12]

31.Developmental toxicity of orally administered thiabendazole in ICR mice. [2001.04]

32.Localization and migration of benzimidazole resistant and susceptible adult Cooperia curticei in the small intestine of sheep after treatment with thiabendazole. [2000.11.01]

33.Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies. [2000.09]

34.[Cholestatic hepatitis ascribed to the use of thiabendazole] [1998.06.06]

35.[Hepatic transplantation for severe ductopenia related to ingestion of thiabendazole] [1997]

36.Comparative efficacies of closantel, ivermectin, oxfendazole, thiophanate and levamisole against thiabendazole resistant Haemonchus contortus in sheep. [1996.08]

37.Subchronic toxicity of thiabendazole (TBZ) in ICR mice. [1996.08]

38.Albendazole versus thiabendazole as therapy for trichinosis: a retrospective study. [1996.06]

39.Murine strongyloidiasis: the effects of cyclosporin A and thiabendazole administered singly and in combination. [1995.04]

40.Fasciola hepatica: mebendazole and thiabendazole pharmacokinetics in sheep. [1994.09]

41.An assessment of thiabendazole-resistant nematodes in some smallholder goat farms of Malaysia using the egg hatch assay method. [1993.12]

42.Critical tests of thiabendazole, oxibendazole, and oxfendazole for drug resistance of population-B equine small strongyles (1989 and 1990). [1993.06]

43.Studies o­n tissue cholinesterase in experimental trichinosis in albino rat. 2 effects of treatment with Mintezol and 5-fluorouracil-Endoxan. [1993.04]

44.Developmental toxicity of orally administered thiabendazole in Sprague-Dawley rats and New Zealand white rabbits. [1993.03]

45.Treatment of mixed Oesophagostomum and hookworm infection: effect of albendazole, pyrantel pamoate, levamisole and thiabendazole. [1993.01]

46.Treatment of Strongyloides stercoralis hyperinfection syndrome with thiabendazole administered per rectum. [1993.01]

47.Sex difference in the nephrotoxicity of thiabendazole in mice depleted of glutathione by treatment with DL-buthionine sulphoximine. [1992.03]

48.Nephrotoxicity of thiazoles structurally related to thiabendazole in mice depleted of glutathione by treatment with buthionine sulfoximine. [1992.01]

49.Prodrugs of thiabendazole with increased water-solubility. [1992]

50.Chronic oral toxicity and carcinogenicity study of thiabendazole in rats. [1991.11]

51.Identification of thiabendazole-resistant cyathostome species in Louisiana. [1991.08]

52.Resistance to thiabendazole, fenbendazole and levamisole in Haemonchus and Trichostrongylus species in sheep o­n a Kenyan farm. [1991.08]

53.Resistance of population-B equine strongyles to thiabendazole, oxfendazole, and phenothiazine (1981 to 1987). [1991.08]

54.[New trial with thiabendazole for treatment of human strongyloidiasis] [1991.03]

55.[Treatment of strongyloidiasis with mebendazole and its combination with thiabendazole] [1990.11]

56.[Levamisole, mebendazole, thiabendazole. Their effectiveness as helminthicides in African patients recently arrived in Cuba. From 1987 to 1988] [1990.05]

57.Effect of selection pressure for thiabendazole resistance o­n fitness of Haemonchus contortus in sheep. [1990.04]

58.Effect of thiabendazole and fenbendazole o­n glucose uptake and carbohydrate metabolism in Trichuris globulosa. [1990.03]

59.Micronodular cirrhosis after thiabendazole. [1989.06]

60.The effects of thiabendazole, mebendazole and cambendazole in normal and immunosuppressed dogs infected with a human strain of Strongyloides stercoralis. [1988]

61.An intervention study using thiabendazole suspension against Strongyloides fuelleborni-like infections in Papua New Guinea. [1987]

62.[Larva migrans "saxoniae": larva migrans infection in Saxony] [2004.01]

63.Field evaluation of the efficacy of fenbendazole in captive wild ruminants. [2005.11.05]

64.Cutaneous larva migrans: case report with current recommendations for treatment. [2005.05]

65.[Purpura in patient with disseminated strongiloidiasis] [2005.05]

66.An unusual case of ectopic tungiasis with pseudoepitheliomatous hyperplasia. [2004.12]

67.Pesticide patch test series for the assessment of allergic contact dermatitis among banana plantation workers in panama. [2004.09]

68.[Severe anguilluliasis in a chronic haemodialysis patient] [2005.01.29]

69.[Nosology and epidemiology of human toxocarosis--the recent situation in Austria] [2004]

70.An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species. [2004.11]

71.Pulmonary strongyloidiasis in a patient receiving prednisolone therapy. [2004.08]

72.Benzimidazole resistance in cyathostomin populations o­n horse farms in western Anatolia, Turkey. [2004.08]

73.[Cutaneous larva migrans: reports of pediatric cases and contamination by Ancylostoma spp larvae in public parks in Taciba, Sao Paulo State] [2004.03]

74.Toxocariasis of the central nervous system: with report of two cases. [2004.03]

75.Strongyloidiasis in patients at a comprehensive cancer center in the United States. [2004.04.01]

76.A survey of anthelmintic resistant nematode parasites in Scottish sheep flocks. [2003.11.03]

77.Cutaneous larva migrans. [2003.10]

78.Comparison of in vitro methods and faecal egg count reduction test for the detection of benzimidazole resistance in small strongyles of horses. [2003.05]

79.Strongyloides hyperinfection in a patient with sarcoidosis. [2003.03]

80.Severe drug rashes in three siblings simultaneously. [2003.05]

81.[Selective vs. mass treatment with antihelminthic drugs: experience in two hyperendemic communities] [2003.01]

82.[Toxocariasis: clinical and laboratory features in 54 patients] [2003.05]

83.Treatment of cutaneous larva migrans and Toxocara infection. [2003.04]

84.[A case of parasitism by Rhabditis sp in a child from Goiania, Goias, Brazil] [2002.09]

85.Massive infestation of cutanea larva migrans. [2002.10]

86.[A case of toxocariasis with eosinophil-rich pleural effusion] [2002.06]

87.[DNA damage in female workers exposed to pesticides in banana plantations at Limon, Costa Rica] [2002.06]

88.Analysis and partial reversal of multidrug resistance to anthelmintics due to P-glycoprotein in Haemonchus contortus eggs using Lens culinaris lectin. [2002.09]

89.Opinion o­n the diagnosis and treatment of human trichinellosis. [2002.08]

90.Induction of aneuploidy in male mouse germ cells detected by the sperm-FISH assay: a review of the present data base. [2002.07.25]

91.Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection. [2002.03]

92.Human strongyloidiasis in AIDS era: its zoonotic importance. [2002.03]

93.One confirmed and six suspected cases of cutaneous larva migrans caused by overseas infection with dog hookworm larvae. [2002.02]

94.Cutaneous larva migrans contracted in England: a reminder. [2001.07]

95.[Disseminated strongyloidiasis] [2001.04.28]

96.Reappearance of a remotely acquired infection. [1997.09]

97.Treatment of larva migrans cutanea (creeping eruption): a comparison between albendazole and traditional therapy. [2001.01]

98.Screening for Strongyloides infection among the institutionalized mentally disabled. [2001.01]

99.High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. [2000.10.12]

100.[A rare cause of asthma exacerbation: systemic anguilluliasis] [2000.02]

Ngày 12/05/2014
PGS.TS. Triệu Nguyên Trung, TS. Nguyễn Văn Chương,
Ths.Bs. Huỳnh Hồng Quang
 

THÔNG BÁO

   Dịch vụ khám chữa bệnh chuyên khoa của Viện Sốt rét-KST-CT Quy Nhơn khám bệnh tất cả các ngày trong tuần (kể cả thứ 7 và chủ nhật)

   THÔNG BÁO: Phòng khám chuyên khoa Viện Sốt rét-KST-CT Quy Nhơn xin trân trọng thông báo thời gian mở cửa hoạt động trở lại vào ngày 20/10/2021.


 LOẠI HÌNH DỊCH VỤ
 CHUYÊN ĐỀ
 PHẦN MỀM LIÊN KẾT
 CÁC VẤN ĐỀ QUAN TÂM
 QUẢNG CÁO

Trang tin điện tử Viện Sốt rét - Ký Sinh trùng - Côn trùng Quy Nhơn
Giấy phép thiết lập số 53/GP - BC do Bộ văn hóa thông tin cấp ngày 24/4/2005
Địa chỉ: Khu vực 8-Phường Nhơn Phú-Thành phố Quy Nhơn-Tỉnh Bình Định.
Tel: (84) 0256.3846.892 - Fax: (84) 0256.3647464
Email: impequynhon.org.vn@gmail.com
Trưởng Ban biên tập: TTND.PGS.TS. Hồ Văn Hoàng-Viện trưởng
Phó Trưởng ban biên tập: TS.BS.Huỳnh Hồng Quang-Phó Viện trưởng
• Thiết kế bởi công ty cổ phần phần mềm: Quảng Ích